Viral polymerase inhibitors

Details Viral polymerase inhibitors Viral polymerase inhibitors

2006-08-29

2006-08-29

Saeed, Kamal A. (Department: 1626)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S466000

Reexamination Certificate

active

07098231

ABSTRACT:
An isomer, enantiomer, diastereoisomer or tautomer of a compound, represented by formula I:wherein A, B, R2, R3, M1, M2, M3, M4, Y1and Z are as defined in claim 1, or a salt thereof, as an inhibitor of HCV NS5B polymerase

REFERENCES:
patent: 5410061 (1995-04-01), Gilmore et al.
patent: 6479508 (2002-11-01), Beaulieu et al.
patent: 6770666 (2004-08-01), Hashimoto
patent: 2003/0108862 (2003-06-01), Kukolj et al.
patent: 2003/0176433 (2003-09-01), Beaulieu et al.
patent: 2003/0232816 (2003-12-01), Beaulieu et al.
patent: 2003/0236251 (2003-12-01), Beaulieu et al.
patent: 2004/0024190 (2004-02-01), Beaulieu et al.
patent: 2004/0082635 (2004-04-01), Hashimoto
patent: 2004/0097438 (2004-05-01), Hashimoto
patent: 0 539 117 (1993-04-01), None
patent: 1 142 880 (2001-10-01), None
patent: 1 162 196 (2001-12-01), None
patent: WO 02/04425 (2002-01-01), None
patent: WO 200204425 (2002-01-01), None
patent: WO 03/007945 (2003-01-01), None
patent: WO 03/014377 (2003-01-01), None
patent: WO 03/010140 (2003-02-01), None
Lauer, G., and Walker, B., “Hepatitis C Virus Infection,” N. Engl. J. Med., vol. 345(1), pp. 41-52 (Jul. 2001), at p. 46, col. 1, lines 23-25.

Affiliated with

Also associated with

Rating

Viral polymerase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Viral polymerase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viral polymerase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3654134